Iq Therapeutics B.V.
Records under this name other than patents Iq Therapeutics B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Iq Therapeutics B.V.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,658,925 | Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof Term ended Term ended Nov 8, 2026 · USPTO record | Term ended | Term ended Nov 8, 2026 | USPTO record |
| US 7,807,415 | Methods of producing stable B-lymphocytes Lapsed on the fee record Ended Oct 5, 2014 · USPTO record | Lapsed on the fee record | Ended Oct 5, 2014 | USPTO record |